Saturday, October 27, 2018 7:18:28 AM
I bought a large position in the CAPV shell (or quasi-shell) yesterday. This is an extremely high-risk investment for a number/variety of reasons, but the risk/reward around this .003 area looks reasonably attractive to me.
Although it has gone largely unnoticed by the market, the changes/activity that occurred in the Nevada filings in January 2017 raised my interest in this shell. CAPV CEO John Duggan registered a new company in Nevada (Blizzard Ventures Inc), did what appears to be a 1:20 reverse split of CAPV, and then merged Blizzard into CAPV. Hence, the name change to Blizzard Ventures that you see on the NVSOS......
https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=U1ErKxAcaD5bXf2t22Kp4Q%253d%253d&nt7=0
When I saw that Duggan filed his NVSOS annual list on October 15, 2018 (about 1.5 months earlier than required) and eliminated Scott Young from a Director position, I decided to take a position in this shell in case some type of corporate activity is getting closer.
Recent CAPV News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/29/2024 05:29:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/29/2024 05:29:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/29/2024 05:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/29/2024 05:27:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/29/2024 05:26:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/29/2024 05:26:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/29/2024 05:25:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/29/2024 05:25:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/29/2024 04:39:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/29/2024 04:08:02 PM
FEATURED Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • Mar 18, 2024 8:51 AM
FEATURED Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation • Mar 18, 2024 8:09 AM
Greenlite Ventures Enters into Strategic Alliance with Woodway USA • GRNL • Mar 15, 2024 4:00 PM
HealthLynked Welcomes David Rosal as New Chief Financial Officer • HLYK • Mar 13, 2024 8:00 AM
ECGI Holdings, Inc. Announces Continued Efforts in Financial Optimization • ECGI • Mar 13, 2024 8:00 AM
PSYC Begins Business Overhaul Process with Consolidation of 10 Previously Issued Convertible Debentures • PSYC • Mar 13, 2024 7:13 AM